Experts has a new look! Let us know what you think of the updates.

Provide feedback

Home

Scholarly Works

The predictive value of intracellular imatinib...

Journal article

The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia

Authors

Hillis CM; Jackson Chornenki NL; Bence-Bruckler I; Busque L; Cote Y; Hamm C; Hasegawa W; Kamel-Reid S; Savoie L; Turner AR

Journal

Leukemia Research, Vol. 88, ,

Publisher

Elsevier

Publication Date

January 2020

DOI

10.1016/j.leukres.2019.106285

ISSN

0145-2126

Associated Experts

Brian Leber

Professor Emeritus, Faculty of Health Sciences

Visit profile

Christopher Hillis

Associate Professor, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology

Medical Subject Headings (MeSH)

Biological Availability Dose-Response Relationship, Drug Female Gene Expression Regulation, Leukemic Genes, abl Humans Imatinib Mesylate Intracellular Space Leukemia, Myelogenous, Chronic, BCR-ABL Positive Male Octamer Transcription Factor-1 Predictive Value of Tests Prognosis Sensitivity and Specificity Treatment Outcome

View published work (Non-McMaster Users)

View published work (McMaster Users)